Učitavanje...
Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia
BACKGROUND: Intimal hyperplasia remains the primary cause of vein graft failure for the 1 million yearly bypass procedures performed using human saphenous vein (HSV) grafts. This response to injury is caused in part by the harvest and preparation of the conduit. The use of Brilliant Blue FCF (FCF) r...
Spremljeno u:
| Izdano u: | J Vasc Surg |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480606/ https://ncbi.nlm.nih.gov/pubmed/27763268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2015.02.028 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|